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Abstract In a novel animal model Octodon degus we tested
the hypothesis that, in addition to genetic predisposition, early
life stress (ELS) contributes to the etiology of attention-deficit
hyperactivity disorder-like behavioral symptoms and the
associated brain functional deficits. Since previous neuro-
chemical observations revealed that early life stress impairs
dopaminergic functions, we predicted that these symptoms
can be normalized by treatment with methylphenidate. In line
with our hypothesis, the behavioral analysis revealed that
repeated ELS induced locomotor hyperactivity and reduced
attention towards an emotionally relevant acoustic stimulus.
Functional imaging using (14C)-2-fluoro-deoxyglucose-au-
toradiography revealed that the behavioral symptoms are
paralleled by metabolic hypoactivity of prefrontal, mesolim-
bic and subcortical brain areas. Finally, the pharmacological
intervention provided further evidence that the behavioral and
metabolic dysfunctions are due to impaired dopaminergic
neurotransmission. Elevating dopamine in ELS animals by
methylphenidate normalized locomotor hyperactivity and
attention-deficit and amelioratedbrainmetabolic hypoactivity
in a dose-dependent manner.
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Attention-deficit hyperactivity disorder (ADHD) is a
heterogeneous syndrome, which is characterized by
behavioral and cognitive dysfunctions, including inatten-
tion, impulsivity and hyperactivity (Kirby et al. 2002;
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Krain and Castellanos 2006; Pasini et al. 2007; Goldman
et al. 1998). Clinical studies have emphasized a genetic
predisposition; however, more recently there is evidence
that adverse environmental factors, such as chronic family
conflicts, decreased family cohesion and parental psy-
chopathology also may play a significant role (Biederman
et al. 1995; Counts et al. 2005; Miller et al. 2006). The vast
majority of animal models, in which the mechanisms and
etiology of attention-deficit hyperactivity disorder (ADHD)
are investigated experimentally, such as the spontaneously
hypertensive rat (Sagvolden 2000), the dopamine trans-
porter knockout mouse (Gainetdinov and Caron 2001), and
others (Davids et al. 2003), are based on the analysis of
genetic predispositions. In contrast, the contribution of
environmental factors on the etiology of ADHD has been
studied in much less detail. The semi-precocial rodent
Octodon degus represents an ideal animal model for the
analysis of the environmental, experience-mediated influ-
ences, since degus are—similar to human babies and unlike
the commonly used altricial laboratory rodents—born with
functional sensory systems (open ears and eyes). Previous
studies in this animal model have shown that repeated
disturbance of the family environment during the first
weeks of life results in behavioral dysfunctions resembling
symptoms of ADHD (Braun et al. 2003). These behavioral
abnormalities are paralleled by changes of dendritic spine
density in prefrontal and limbic brain areas (Helmeke et al.
2001; Poeggel et al. 2003a), which can be normalized by a
chronic treatment with methylphenidate (Zehle et al. 2007),
a compound that is used to treat ADHD symptoms in
children and adolescents.
The aim of this study was to test the hypothesis that
environmental factors such as early life adversity con-
tributes to the etiology of ADHD-like behavioral symp-
toms, and results in dysfunctional activation patterns in
limbic and prefrontal regions. Based on previous observa-
tions that ELS significantly alters dopaminergic innerva-
tion patterns in the medial prefrontal cortex and in the
nucleus accumbens (Braun et al. 2000; Gos et al. 2006;
Kunzler et al. 2015) and reduces dopaminergic functions
(Jezierski et al. 2007), we predicted that treatment with
methylphenidate should ‘‘normalize’’ the ELS-induced
ADHD-like behavioral and brain dysfunctions.
Materials and methods
Experimental subjects
Octodon degus (‘‘trumped tailed rat’’) were bred in our animal
facility and housed in wire cages (l/w/h 50 cm 9
42 cm 9 67 cm) in air-conditioned rooms (22 C) under a
12/12 h light/dark cycle. Drinking water, rat diet pellets and
vegetables were available ad libitum. Families consisted of an
adult couple and their offspring. All experiments were per-
formed in accordance with the European Community’s
Council Directive of 24 Nov 1986 (86/609/EEC), the exper-
imental protocols were approved by the ethics committee of
the government of the state of Saxony-Anhalt according to the
German guidelines for the care and use of animals in labora-
tory research (§8, Abs. 1, 25.05.1998).
Experimental design (Fig. 1)
Rearing conditions
Early life stress group (ELS): pups were exposed to daily
parental separation from postnatal day (PND) 1 until PND
21. During the separation period (1 h per day) the animals
were removed from their parents and siblings and indi-
vidually placed in small opaque isolation cages (size:
39 9 10 9 10 cm) with fresh bedding. Acoustic and
olfactory but no direct social contact between the siblings
was possible.
Control group (CON): pups of this group remained undis-
turbed in their home cages with their family until PND 21.
Behavioral analysis
Locomotor activity (exploratory behavior and impulsivity)
The animals of the ELS and CON groups and the phar-
macological treatment groups (see below) were tested in a
standard open field (OF) test. The size of the OF was
80 9 80 9 40 cm, with opaque dark-gray plastic walls and
floor. The open field arena was subdivided into a center
part, which had the same area size as the peripheral region
along the walls. The animals were individually placed in
the open field for 5 min/test and the behavior was recorded
using a video tracking system (EthoVision, NOLDUS,
Wageningen, The Netherlands), delivering data sets for the
following parameters:
• Running activity: (center plus periphery of the OF) was
measured as distance (m) covered by each animal
during the 5-min OF test.
• Center exploration was defined as horizontal activity in
the center area of the open field during the 5-min test
and calculated as ratio of the running distance (m) cov-
ered in the center area relative to the total OF running
distance.
• Rearing was measured by counting the numbers of
vertical rearing movements.
• Self-grooming, i.e., the number of grooming activities
on various body parts including back, head, face, nose,
ears, etc.
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Attentiveness
Animals of the ELS and CON groups and the pharmaco-
logical treatment groups (see below) were tested in a
modified OF test (Fig. 2) that allowed quantitative analysis
of the responsiveness (‘‘attentiveness’’) towards an acoustic
emotionally relevant stimulus (play and contact vocaliza-
tions emitted from young degus). The open field arena was
subdivided into 4 quadrants of same area size. From one
corner of the arena degu vocalizations were presented from
a loudspeaker, which was not visible to the test animal, the
respective quadrant was defined as tone quadrant. The
animals were individually placed in the open field for
5 min/test and the following parameters were assessed.
• Running activity in the tone quadrant (% of total
running activity)
• Time spent (s) in the tone quadrant
• Vertical activity: see above
• Self-grooming: see above
Pharmacological intervention
Standard open field test #1: effects of ELS on exploratory
and impulsive behavior
On PND 22, the behavioral parameters outlined above were
compared in pharmacologically untreated unstressed CON
(n = 29) and ELS animals (n = 30) as described above.
Standard open field test #2: effects of methylphenidate
on exploratory and impulsive behavior in ELS and CON
animals
The animals of stressed (ELS) and control (CON) litters
were randomly assigned to the following pharmacological
treatment groups (Fig. 1); a split litter design was applied
to avoid litter effects.
• Saline-treated ELS animals (ELS-SAL, n = 11) and
saline-treated unstressed controls (CON-SAL,
n = 13).
• 1 mg/kg methylphenidate-treated ELS animals (ELS-
MP1, n = 9) and 1 mg/kg methylphenidate-treated
unstressed controls (CON-MP1, n = 8).
• 5 mg/kg methylphenidate-treated ELS animals (ELS-
MP5, n = 10) and 5 mg/kg methylphenidate-treated
unstressed controls (CON-MP5, n = 8).
Fig. 1 Experimental design,
note that animals for behavioral
and 2FDG experiments are from
different cohorts
Fig. 2 Behavioral analysis of attentiveness using a modified open
field arena. A loudspeaker in one corner emitted play vocalizations
from siblings
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Modified open field test #1: effects of ELS on attentiveness
On PND 22, the behavioral parameters outlined above were
compared in pharmacologically untreated unstressed CON
(n = 24) and ELS animals (n = 25) in the modified open
field test as described above (Helmeke et al. 1998; Poeggel
et al. 2003a; Helmeke et al. 2001).
Modified open field test #2: effects of methylphenidate
on attentiveness in ELS and CON animals
The animals of stressed (ELS) and control (CON) litters
were randomly assigned to the following pharmacological
treatment groups (Fig. 1), a split litter design was applied
to avoid litter effects.
• Saline-treated ELS animals (ELS-SAL, n = 8) and
saline-treated unstressed controls (CON-SAL, n = 8).
• 1 mg/kg methylphenidate-treated ELS animals (ELS-
MP1, n = 9) and 1 mg/kg methylphenidate-treated
unstressed controls (CON-MP1, n = 8).
• 5 mg/kg methylphenidate-treated ELS animals (ELS-
MP5, n = 8) and 5 mg/kg methylphenidate-treated
unstressed controls (CON-MP5, n = 5).
For the behavioral analysis during the respective open
field test #2 the animals received an intraperitoneal (i.p.)
injection of either 0.2 ml sterile saline, 1 mg/kg methyl-
phenidate (MP1) or 5 mg/kg methyphenidate (MP5) solu-
tion (MP: Sigma-Aldrich, Steinheim, Germany),
respectively, which was applied directly after open field
test #1. After the injection the animals were returned to the
home cage for 45 min and then individually exposed to
open field test #2. Between each test the open field was
wiped with 2 % acidic acid. The daily testing routine was
balanced across the experimental groups.
Statistical analysis
Open field test #1: effects of ELS on exploratory, impulsive
behavior and attentiveness
For the described parameters, the effect of rearing condi-
tion (REAR) was tested using Student’s t test with a sig-
nificance level set at p\ 0.05, (GraphPad Prism version
5.00, GraphPad Software, San Diego, CA, USA).
Open field test #2: effects of methylphenidate
on exploratory, impulsive behavior and attentiveness
The effects of the different MP doses on the two rearing
conditions were analyzed using a two-way ANOVA with
the factors rearing condition (REAR) and pharmacological
treatment (PHARM). Since the aim of this study was to test
the ‘‘therapeutic’’ effects of MP treatment the values of the
CON-SAL control group were defined as baseline to which
the data of all experimental groups were referred using a
one-sample t test as post hoc test. The level of significance
was set to p B 0.05 (GraphPad Prism version 5.00,
GraphPad Software, San Diego, CA, USA).
Functional imaging
2-FDG-autoradiography
On PND 22, males of stressed (ELS) and control (CON)
litters were randomly assigned to the following pharma-
cological treatment groups (Fig. 1).
• Saline-treated early stressed animals (ELS-SAL,
n = 5) and saline-treated unstressed controls (CON-
SAL, n = 5).
• 1 mg/kg MP-treated stressed animals (ELS-MP1,
n = 5) and 1 mg/kg MP-treated unstressed controls
(CON-MP1, n = 5).
• 5 mg/kg MP-treated stressed animals (ELS-MP5,
n = 5) and 5 mg/kg MP-treated unstressed controls
(CON-MP5, n = 5).
Male siblings of CON or ELS litters were placed in an
opaque experimental chamber. After 10 min habituation
each animal received an i.p. injection of 0.2 ml of a
Fig. 3 Brain areas, quantitatively analyzed in the 2FDG experiment:
infralimbic cortex (IL), prelimbic cortex (PL), ventral (vOFC) and
lateral orbitofrontal cortex (lOFC), anterior cingulate cortex (ACd),
basolateral amygdala (BLA), lateral amygdala (LA), medio-dorsal
thalamus (MD), auditory cortex (Au), caudate putamen (CPu), dentate
gyrus (DG), hippocampal subregions CA1, CA3, medial geniculate
nucleus (MGN), mammillary nuclei (MM), nucleus accumbens
(Nacc), substantia nigra (SN), somatosensory cortex (SSC)
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mixture of 9 lCi 2-fluoro-2-deoxy-D-glucose [14C(U)]
2-FDG (American Radiolabeled Chemicals) in sterile
0.9 % saline with either 1 or 5 mg/kg MP solution or
without MP, respectively. After 45 min the animals were
decapitated, their brains quickly removed and rapidly fro-
zen. 40-lm frozen frontal sections were mounted on glass
slides, immediately dried at a temperature of 40 C on a
heating plate and exposed on X-ray Film (Kodak Biomax
MR). Selected regions of interest (ROI) were densitomet-
rically quantified using NIH Image software. 2-FDG
uptake was calculated for each ROI as relative value to the
mean gray value of the corpus callosum, which served as
internal control. The following brain regions (Fig. 3) were
quantitatively analyzed: infralimbic cortex (IL), prelimbic
cortex (PL), ventral (vOFC) and lateral orbitofrontal cortex
(lOFC), anterior cingulate cortex (ACd), basolateral
amygdala (BLA), lateral amygdala (LA), medio-dorsal
thalamus (MD), auditory cortex (Au), caudate putamen
(CPu), dentate gyrus (DG), hippocampal subregions CA1,
CA3, medial geniculate nucleus (MGN), mammillary
nuclei (MM), nucleus accumbens (Nacc), substantia nigra
(SN), and somatosensory cortex (SSC).
Statistical analysis
Since no hemispheric differences were found, the values
for the hemispheres were pooled and a two-way ANOVA
with the factors rearing condition (REAR) and pharmaco-
logical treatment (PHARM) was applied. Again the values
of the CON-SAL control group were defined as baseline to
which the data of all experimental groups were referred
using a one-sample t test as post hoc test. The level of
significance was set to p B 0.05.
Preparation of figures
Digital images were processed using Adobe Photoshop 7.0
(Adobe Systems Incorporated, USA) and assembled into




Exploratory activity in the standard open field
Test #1: ELS increases exploratory motor activity and
impulsivity t Test revealed a significant increase of total
running activity (p = 0.024) and running activity in the
center of the OF arena (p = 0.004) in the ELS group
compared to the CON group (Fig. 4a). Rearing and
grooming did not differ between the two groups (data not
shown).
Test #2: methylphenidate ‘‘normalizes’’ running activity
and differentially affects ELS and CON animals Total
running activity: two-way ANOVA revealed significant
main effects for the factor PHARM (F2,53 = 27.33,
p\ 0.0001) as well as a significant interaction of
REAR 9 PHARM (F2,53 = 5.401, p = 0.007). Post hoc
one-sample t test revealed that treatment of ELS animals
with 1 mg/kg MP decreased running activity down to the
level of the CON-SAL group (‘‘therapeutic’’ effect),
whereas 5 mg/kg MP significantly increased running
activity in the ELS group above the level of the CON-SAL
group (p\ 0.01) (Fig. 4b). Treatment of CON animals
with 1 mg/kg MP (p\ 0.001) or 5 mg/kg MP (p\ 0.001)
increased running activity compared to the CON-SAL
group (Fig. 4b).
Center activity: two-way ANOVA revealed significant
main effects for the factor REAR (F1,53 = 4.675,
p = 0.035), PHARM (F2,53 = 11.99, p\ 0.0001) and a
significant interaction of REAR 9 PHARM
(F2,53 = 4.754, p = 0.0126). Post hoc test revealed that
ELS-SAL animals displayed significantly higher center
activity compared to CON-SAL animals (p\ 0.01)
(Fig. 4c). However, no ‘‘therapeutic’’ normalization of
center activity was observed after treatment of ELS ani-
mals with 1 mg/kg MP, since these animals remained more
active in the center compared to the CON-SAL group
(p\ 0.05). Treatment of ELS animals with 5 mg/kg MP
further increased center activity (p\ 0.001, Fig. 2c)
compared to the CON-SAL group. In addition, treatment of
CON animals with 1 mg/kg MP (p\ 0.05) or 5 mg/kg MP
(p\ 0.01) increased center activity compared to the CON-
SAL group (Fig. 4c).
Rearing activity: two-way ANOVA revealed significant
main effects for the factor PHARM (F2,53 = 6.023,
p = 0.0095). Post hoc test revealed significantly decreased
rearing activity in the CON-MP5 group compared to the
CON-SAL group (p\ 0.05, data not shown).
Grooming behavior: two-way ANOVA revealed signif-
icant main effects for the factor REAR (F1,53 = 7.244,
p\ 0.0001). Post hoc test revealed significantly decreased
grooming activity in the CON-MP5 group compared to the
CON-SAL group (p\ 0.05, data not shown).
Attentiveness in the modified open field
Test #1: ELS reduces attentiveness and increases grooming
and rearing behavior in ELS animals t Test revealed a
significant reduction of running activity and time spent in
the tone quadrant in the ELS group compared to the CON
group (running activity: p = 0.008, time spent:
Brain Struct Funct (2017) 222:765–780 769
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p = 0.0163) (Fig. 5a, c, d). In contrast, the parameters
rearing and grooming were increased in the ELS animals
compared to the CON animals (p = 0.042, grooming:
0.0012) (Fig. 5b).
Test #2: methylphenidate treatment ‘‘normalizes’’ atten-
tiveness and grooming behavior in a dose-dependent
manner Running activity and time spent in the tone
quadrant: two-way ANOVA revealed a significant inter-
action of REAR 9 PHARM (F2,43 = 4.292, p = 0.02) for
running activity. Similar to the non-injected ELS group
(see above Fig. 5), the ELS-SAL group displayed signifi-
cantly lower running activity in the tone quadrant com-
pared to the CON-SAL group (p\ 0.05) (Fig. 6a).
Similarly, time spent in the tone quadrant was significantly
lower in the ELS-SAL group compared to the CON-SAL
group (p\ 0.01) (Fig. 6b). Treatment of the ELS group
with 1 mg/kg MP ‘‘normalized’’ running activity as well as
time spent in the tone quadrant to the level of the CON-
SAL group (Fig. 6a, b).
In contrast, treatment of ELS animals with 5 mg/kg MP
had no therapeutic effect on relative running activity since
these animals displayed a decrease of this parameter
(p\ 0.01) compared to the CON-SAL group (Fig. 6a).
However, a partial normalization with this dose was seen
for the time spent in the tone quadrant (Fig. 6b).
Grooming behavior: two-way ANOVA revealed signif-
icant main effects for the factor PHARM (F2,43 = 7.918,
p = 0.0012), the factor REAR (F1,43 = 6.302,
p = 0.0159) and the interaction of REAR 9 PHARM
(F2,43 = 3.288, p = 0.0469). Similar to the non-injected
CON and ELS groups (see above Fig. 5b), the SAL-in-
jected ELS animals showed increased grooming (p\ 0.05)
behavior (Fig. 6c). Grooming behavior was completely
‘‘normalized’’ in the ELS group by treatment with 1 mg/kg
MP, whereas 5 mg/kg MP completely abolished grooming
behavior (Fig. 6c).
Rearing activity: two-way ANOVA revealed significant
main effects for the factors PHARM (F2,43 = 17.52,
p\ 0.0001) and REAR (F1,43 = 8.476, p = 0.0057).
Similar to the non-injected CON and ELS groups (Fig. 5b),
the ELS-SAL animals showed increased rearing (p\ 0.05)
behavior (Fig. 6d). The dose of 5 mg/kg MP reduced
rearing behavior of ELS animals down to the level of the
CON-SAL group (Fig. 6d).
Functional Imaging
High metabolic activities were found in the prefrontal ACd,
PL and OFC, as well as in sensory cortices, such as the
SSC and Au and also in the subcortical CPu, Nacc, thala-
mic MD and hippocampal DG. Lower activities were
observed in the prefrontal IL, the hippocampal CA1 and
CA3 and in the amygdala (BLA, LA) (Fig. 7).
Two-way ANOVA revealed main effects for REAR in
all analyzed regions, except the CA1 and CA3. A main
effect of PHARM was found for the lOFC (F2,24 = 3.418),
ACd (F2,24 = 3.774), MD (F2,24 = 4.551), SN
Fig. 4 Effect of ELS and pharmacological treatment with methyl-
phenidate (MP) on motor activity in the standard open field. Open
field test #1: a effects of ELS on running activity in the total arena
(left Y-axis) and relative running activity in the center of the arena
(right Y-axis). Open field test #2: b effect of MP on total running
activity in relation to the CON-SAL group (black line). c Effect of
MP on center running activity related to the CON-SAL group (black
line)
770 Brain Struct Funct (2017) 222:765–780
123
Fig. 5 Effect of ELS on attentiveness in the modified open field. Open
field test #1: a Running activity in the tone quadrant (% of total running
activity, left Y-axis) and time, spent in the tone quadrant (in seconds, right
Y-axis). b Self-grooming (left) and rearing (right) activity. Graphic
illustration of the running activities in the modified open field arena in
CON (c) and ELS animals (d); red arrow indicates the tone quadrant
Fig. 6 Effects of MP treatment
on attentiveness in the modified
open field. Open field test #2:
a effect of MP on running
activity in the tone quadrant
related to the CON-SAL group
(black line). b Effect of MP on
the time spent in the tone
quadrant related to the CON-
SAL group (black line). c Effect
of MP on self-grooming related
to the CON-SAL group (black
line). d Effect of MP on rearing
related to the CON-SAL group
(black line)
Brain Struct Funct (2017) 222:765–780 771
123
(F2,24 = 16.17) and VTA (F2,24 = 6.829). An interaction
of REAR 9 PHARM was found for the Nacc
(F2,24 = 4.217) and SN (F2,24 = 7.486).
Effects of ELS on metabolic brain activity
Post hoc test revealed that ELS experience resulted in a
significant decrease of metabolic activity in the prefrontal
ACd (p\ 0.05), PL (p\ 0.01), IL (p\ 0.001) (Fig. 8),
vOFC (p\ 0.001) and lOFC (p\ 0.001) (Fig. 9),
dopaminergic and strongly dopamine innervated regions
CPu (p\ 0.01), Nacc (p\ 0.01) (Fig. 10), SN (p\ 0.001)
(Fig. 11) and VTA (p\ 0.05) (Fig. 12), in the limbic BLA
(p\ 0.05), LA (p\ 0.05) (Fig. 13) and MM (p\ 0.05)
(Fig. 12), and in the auditory MGN (p\ 0.01) (Fig. 12)
when compared to the non-stressed CON-SAL group. No
significant differences between the ELS and CON group
were observed in MD (Fig. 13), CA1, CA3, DG (Fig. 14),
Au and SSC (Fig. 15).
Effects of MP treatment on metabolic brain activity
Therapeutic effects of MP treatment were found in the
prefrontal IL and in the LA and BLA. MP1 treatment
completely normalized metabolic activity in the IL of ELS
animals to the levels of the CON-SAL group (Fig. 8) and
partly reversed activity in the LA and BLA (Fig. 13),
whereas no therapeutic effects could be observed for the
other analyzed brain regions.
Similarly, MP5 treatment increased metabolic activity
of ELS animals back to control levels in the IL (Fig. 8) as
well as in the LA and BLA (Fig. 13). In the CON group,
MP1 significantly elevated metabolic activity in the CPu
(Fig. 10), CA3, DG (Fig. 14), MM, MGN (Fig. 12), ACd
(Fig. 8), and in the vOFC and lOFC (Fig. 9) when com-
pared to the CON-SAL group. In the CON-MP5 group,
significantly increased metabolic activity was observed in
the CPu, Nacc (Fig. 10), SN (Fig. 11), VTA (Fig. 12), MD
(Fig. 13), SSC and Au (Fig. 15) compared to the CON-
SAL group.
Discussion
The present study on Octodon degus confirmed our
hypothesis that environmental factors such as ELS induce
ADHD-like behavioral symptoms, including locomotor
hyperactivity and inattentiveness towards an emotionally
meaningful acoustic stimulus. Furthermore, ELS induced
metabolic hypoactivity in prefronto-limbic brain areas.
Finally, we were able to provide evidence that the
behavioral and brain metabolic dysfunctions are at least in
part caused by abnormal dopamine levels. Treatment of
ELS animals with methylphenidate (MP) and thereby
elevating dopamine levels ameliorated the behavioral
dysfunctions as well as brain hypoactivity in the pre-
frontal infralimbic cortex and the limbic basolateral and
lateral amygdala.
Fig. 7 Pseudocolor images of frontal sections indicating 2-FDG uptake as measurement comparing metabolic brain activity in the CON and ELS
group under vehicle and MP treatment conditions
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Fig. 8 Quantitative analysis of
metabolic activity in mPFC
regions under vehicle and MP
treatment conditions related to
the CON-SAL group (black
line)
Fig. 9 Quantitative analysis of
metabolic activity in the ventral
and lateral orbitofrontal cortex
(OFC) under vehicle and MP
treatment conditions in relation
to the CON-SAL group (black
line)
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ELS-induced ADHD-like behavioral symptoms
In line with previous observations (Braun et al. 2003), the
present study revealed that ELS exposure results in
hyperactive behavior. Moreover, increased exploration in
the center area of the open field and increased self-
grooming are indicative of reduced impulse control (Col-
orado et al. 2006; Hall et al. 2000). The reduced running
activity and time spent in the quadrant emitting socially
attractive conspecific vocalizations is indicative of reduced
attentiveness and impaired social interest towards an
emotionally relevant acoustic stimulus in ELS animals. In
addition, enhanced self-grooming as measured during the
modified open field test may be indicative of enhanced
sensitivity, impaired behavioral inhibition and reduced
anxiety during exposure to novelty and aversive situations
(Clement et al. 1995; Clement and Chapouthier 1998;
Ramos et al. 1997), i.e., situations, which produce rela-
tively higher inhibition responses such as a session in a
brightly illuminated open field (Dı´az-Mora´n et al. 2014;
Smolinsky et al. 2009).
Treatment of ELS animals with methylphenidate
(MP) ameliorated ADHD-like behavioral symptoms
The behavioral symptoms observed in our animal model
are reminiscent of main features of ADHD, for which
the role of the dopaminergic midbrain areas and the
connected mesolimbic and nigrostriatal system has been
emphasized (Carey et al. 1998; Oades et al. 2005;
Fig. 10 Quantitative analysis
of metabolic activity in the
striatal CPu and Nacc under
vehicle and MP treatment
conditions in relation to the
CON-SAL group (black line)
Fig. 11 Quantitative analysis
of metabolic activity in the SN
under vehicle and MP treatment
conditions in relation to the
CON-SAL group (black line)
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Russell et al. 1995; Viggiano et al. 2002; Kirley et al.
2002; Solanto 2002). Evidence from research in humans
as well as in animal models implicates a dysregulation of
the dopaminergic and norepinephrinergic systems in
frontostriatal brain circuits in the pathophysiology of
ADHD (Biederman and Faraone 2005). Our previous
work demonstrated that ELS in degus induces dramatic
changes in the density and function of dopaminergic and
serotonergic fiber innervation in prefrontal and limbic
brain regions (Helmeke et al. 2008; Seidel et al. 2008;
Braun et al. 2000; Gos et al. 2006; Poeggel et al. 2003b;
Kunzler et al. 2015; Hall et al. 1998; 1999; Jezierski
et al. 2007). Thus, the aim was to test the most fre-
quently used drug for treating ADHD methylphenidate
(MP) (Sagvolden 2000), a stimulant that acts by block-
ing dopamine and norepinephrine transporters. Treat-
ment of ELS animals with 1 mg/kg MP completely
normalized motor hyperactivity in the standard open
field and also attentiveness (reactivity towards con-
specific vocalizations) and reduced impulse control (self-
grooming) in the modified open field. These findings are
in line with studies in behaviorally abnormal, ADHD-
type genetic rat strains reporting an amelioration of
hyperactivity symptoms under low doses of MP (Kishi-
kawa et al. 2014). On the other hand, our results are
somewhat contradictory to a study in which ADHD
symptoms were induced by rearing rats in social isola-
tion and impoverished environment, where MP failed to
normalize the behavioral dysfunctions (Yates et al.
2012).
It is important to point out that MP treatment evoked
quite opposite behavioral effects in ADHD-type ELS and
in behaviorally normal CON animals, which indicates that
ELS induces changes in dopaminergic functions, e.g.,
receptors and/or transporter systems. In contrast to the
therapeutic effects of low-dose MP in the ELS ADHD-type
animals, MP treatment in control animals in general
induced hyperactive behavior and reduced attentiveness.
Pharmacological studies, which tested the behavioral
effects of MP treatment in behaviorally normal rodents,
also observed typical stimulant effects such as increased
locomotor activity (Thanos et al. 2015; Haleem et al. 2015;
Berridge et al. 2006), but in contrast to our study improved
attention (Bhattacharya et al. 2015).
Fig. 12 Quantitative analysis
of metabolic activity in the
MGN, VTA and MM under
vehicle and MP treatment
conditions in relation to the
CON-SAL group (black line)
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ELS-induced metabolic hypoactivity in prefronto-
limbic brain regions
The present study is the first to show that exposure to ELS
results in lower metabolic activity in executive/motor
pathways including the prefrontal cortical areas OFC, ACd,
PL and also the substantia nigra (SN). It is tempting to
speculate that ELS hypoactivity of these regions is causally
linked to the observed ADHD-like behavioral symptoms,
analogous to brain dysfunctions found in ADHD patients
(Dahmen et al. 2012; Rubia et al. 2005; Smith et al. 2006).
Additionally, we found that ELS animals display
reduced metabolic activity in brain regions mediating
impulse control such as the ventral striatum (Nacc) (Feja
et al. 2014), the ACd and IL (Tsutsui-Kimura et al. 2016)
and also in affective/learning/motivation pathways,
including the prefrontal cortex, the VTA, Nacc, the
amygdala (BLA, LA) and the mammillary bodies.
The ELS-induced prefronto-limbic/prefrontostriatal
hypofunctionality observed in our animal model is in
accordance with findings of fMRI studies in ADHD
patients, which have shown task-related hypofunction in
the mPFC (Casey et al. 1997; Rubia et al. 1999). Compared
to healthy controls, individuals with ADHD are also
reported to show abnormalities in brain activation during
response inhibition, including hypoactivation of the ante-
rior/mid-cingulate cortex (Tamm et al. 2004). ADHD
children show a slightly different cognitive profile at
6–10 years of age that was paralleled by a relative lack of
or delay in the maturation of ventral frontostriatal circuitry
(Durston et al. 2003). Additionally, fMRI studies in ADHD
patients revealed that striatal dysfunctions are directly
connected with altered motor behavior (Teicher et al.
2000).
MP treatment partly ameliorated ELS-induced
metabolic hypoactivity in prefronto-limbic brain
areas
Most of the affected brain areas in ELS animals are regions
of the fronto-striatal system, which is modulated by
dopaminergic input, and it is believed that dysregulation of
dopaminergic modulation in these circuits contributes to
the pathophysiology of ADHD (Biederman and Faraone
2005). It is tempting to speculate that ELS impairs the
maturation of dopaminergic functions, which might affect
Fig. 13 Quantitative analysis
of metabolic activity in the MD,
LA and BLA under vehicle and
MP treatment conditions in
relation to the CON-SAL group
(black line)
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Fig. 14 Quantitative analysis
of metabolic activity in the
hippocampal CA1, CA3 and DG
under vehicle and MP treatment
conditions in relation to the
CON-SAL group (black line)
Fig. 15 Quantitative analysis
of metabolic activity in the Au
and SSC under vehicle and MP
treatment conditions in relation
to the CON-SAL group (black
line)
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metabolic activity in limbic and prefrontal brain circuits.
To test whether elevating dopamine level ‘‘normalizes’’
metabolic brain activity, we treated young ELS animals
with methylphenidate. Indeed, a therapeutic effect of MP
treatment was observed, i.e., metabolic activity was
upregulated in the IL as well as in the LA and BLA of MP-
treated ELS animals. The IL is involved in the regulation of
attentiveness and behavioral flexibility (Oualian and Gis-
quet-Verrier 2010; Ragozzino et al. 1999) and the IL–
amygdala pathway in the regulation of emotional behavior
(Sotres-Bayon and Quirk 2010; Biederman and Faraone
2005; Cunningham et al. 2002), which at least in part
matches the behavioral effects of MP treatment, in partic-
ular the normalization of attentiveness and reactivity
towards an emotionally relevant tone stimulus.
Taken together our study revealed that ELS as envi-
ronmental challenge induces metabolic hypoactivity in
brain pathways mediating attentiveness, which are paral-
leled by behavioral traits reminiscent of human ADHD.
These dysfunctions are due to dopaminergic dysfunctions
as they are ameliorated by MP treatment. Our results
underline the importance to consider an adverse childhood
environment as an important factor in the etiology of
ADHD-like behavioral abnormalities.
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